From Epidemiology to Market Pulse: In-Depth Outlook on Hantavirus Pandemic Risk in 2026

1. Virus Profile: Analysis of Hantavirus Characteristics

Hantavirus is a group of RNA viruses that naturally infect rodents worldwide, causing approximately 200k infections annually. The fatality rate varies greatly depending on the strain, with Andes virus-induced hantavirus pulmonary syndrome (HPS) reaching death rates of 30% to 50%. Most hantaviruses do not transmit between humans; humans are typically "terminal hosts"—infection occurs through inhalation of aerosols contaminated with rodent excreta, resulting in sporadic and localized outbreaks.

However, the "main character" of the current Atlantic cruise outbreak—the Andes virus—is the only known hantavirus capable of human-to-human transmission. To date, eight cases have been reported on the cruise ship named "Honduras," including three deaths. The infected passengers come from 12 different nationalities, with suspected cases also reported in Spain, the UK, Switzerland, and other countries related to the cruise. This potential for human transmission has sparked deep concerns about the spread of the outbreak.

2. Epidemiological Model Projections: Transmission Dynamics of Andes Virus

From a virological perspective, the Andes virus has extremely limited human-to-human transmission capability, fundamentally different from COVID-19. WHO spokesperson Lindmeier explicitly stated at a press conference: "Even among those sharing a cabin, not all individuals will necessarily get infected. Its mode of transmission is entirely different from that of COVID-19." Epidemiological evidence further supports this: a flight attendant who had close contact with a confirmed patient tested negative; another contact who was not a close partner also showed no signs of infection.

This indicates that human transmission of Andes virus requires "close, prolonged contact," typically limited to family members, intimate partners, or healthcare workers, with very low transmission efficiency. In the context of global transportation networks, this transmission efficiency cannot support the exponential growth curve needed for a pandemic.

Additionally, public health systems worldwide have initiated rapid responses: WHO has activated coordination mechanisms under the International Health Regulations, with countries like the US, Canada, and Singapore tracking contacts and implementing quarantine measures. The "Honduras" cruise is currently heading to the Canary Islands in Spain for passenger evacuation, with the area under strict quarantine and complete public separation. The 42-day medical monitoring period begins from the last contact with a confirmed case, providing a sufficient window to break the transmission chain.

3. WHO and Expert Consensus: Global Pandemic Risk is "Absolutely Very Low"

WHO has clearly assessed the risk level of hantavirus outbreaks: the risk of large-scale outbreaks is "absolutely very low," and the risk of transmission to the general population is also extremely low. Hong Kong's Director of Health, Lo Chung-mau, pointed out that WHO's assessment indicates a low risk of recent hantavirus evolution into a global pandemic. Fernando Espejo, a veterinary medicine professor at Madrid European University, is even more confident—he asserts that the possibility of hantavirus triggering a new wave of outbreaks is "zero."

The probability of a "global pandemic" event is estimated between 0.5% and 2%, which is extremely low. It should be clarified that while Andes virus has limited human-to-human transmission ability, it is not entirely absent—this remains the main source of pandemic risk. Nonetheless, at this probability level, the "pandemic" speculation is more driven by emotional panic narratives rather than epidemiological data-based rational judgment.

4. Current Market Trading Logic and Strategy Recommendations

Compared to the very low probability of a pandemic, financial markets react more violently—primarily reflecting short-term pricing of "uncertainty premiums," rather than long-term valuation of substantive risks.

Following the outbreak news, A-share virus prevention and control sector stocks and overseas vaccine concept stocks experienced event-driven pulses upward. Moderna confirmed early collaboration with the US Army Medical Research Institute of Infectious Diseases on hantavirus vaccines, causing its stock to surge nearly 12% on the same day. Meanwhile, domestic virus prevention stocks also rallied: Wansun Bio rose 19%, Kaipu Bio increased over 15%, Daan Gene hit the daily limit, and Wantai Biological rose 9%. Nine hantavirus antibody test kits have been approved domestically, with companies like Wantai Bio, BGI-backed Beijing BGI Jibai Biological, and others gaining investor attention. Additionally, Traws Pharma announced the initiation of clinical development of candidate hantavirus therapeutics.

Trading strategy suggestions are as follows:

· Short-term (1-3 weeks): Maintain a wait-and-see stance. The current rally in epidemic prevention concept stocks is mainly driven by news catalysts; some stocks have already shown 20CM-level impulsive bullish candles. The short-term emotional high risks accumulation, so chasing highs is not recommended.

· Medium-term (1-3 months): If the outbreak unexpectedly spreads (e.g., secondary cases outside the cruise, surge in cases in South America), closely monitor companies with hantavirus test reagent reserves—such as Wantai Bio (with domestic registration), BGI (with registered products from BGI Jibai Biological), and vaccine pipeline stocks like Wansun Bio and Zhifei Biological. Testing-related stocks tend to have "quick short-term performance realization and high emotional elasticity," suitable for event-driven trading; vaccine stocks are better for medium- to long-term positioning, with key catalysts being progress and clinical data releases from multinational companies like Moderna.

· Long-term (over 6 months): The probability of a pandemic is extremely low, and the theme's popularity is likely to decay within 1-3 months unless there are viral mutations or systemic outbreaks in South America. Otherwise, such thematic trading strategies carry mean reversion risks. It is recommended to adopt quick entry and exit, with disciplined profit-taking and stop-loss.

Core risk monitoring indicators: First, whether the number of confirmed cases among cruise ship contacts increases; second, whether there is an abnormal rise in cases reported in the Andes virus region of South America; third, whether viral gene sequencing shows adaptive mutations. In the absence of worsening signals in these indicators, this round of thematic trading should focus on short-term emotional speculation, not betting on a "long-term pandemic narrative."